Advanced searches left 3/3
Search only database of 8 mil and more summaries

Measles Vaccine Age

Summarized by PlexPage
Last Updated: 02 July 2021

* If you want to update the article please login/register

General | Latest Info

Measles is a very contagious disease caused by viruses. It spreads through the air when an infected person coughs or sneezes. Measles starts with a cough, runny nose, red eyes, and fever. Then a rash of tiny, red spots breaks out. It starts in the head and spreads to the rest of the body. Measles can be prevented with MMR Vaccine. Vaccines protect against three diseases: measles, mumps, and rubella. Cdc recommends children get two doses of MMR Vaccine, starting with the first dose at 12 through 15 months of age, and the second dose at 4 through 6 years of age. Teens and adults should also be up to date on their MMR vaccination. Mmr Vaccine is very safe and effective. Two doses of MMR Vaccine are about 97% effective at preventing measles; one dose is about 93% effective. Children may also get MMRV Vaccine, which protects against measles, mumps, rubella, and varicella. This vaccine is only licensed for use in children who are 12 months through 12 years of age. Before the measles vaccination program started in 1963, estimated 3 to 4 million people get measles each year in the United States. Of these, approximately 500 000 cases were reported each year to CDC; of these, 400 to 500 died, 48 000 were hospitalize, and 1 000 developed encephalitis from measles. Since then, widespread use of measles virus - containing vaccine has led to a greater than 99% reduction in measles cases compared with the pre - Vaccine era. However, measles is still common in other countries. Unvaccinated people continue to get measles while abroad and bring the disease into the United States and spread it to others.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Measles

If you do not have immunity against measles, mumps, and rubella and are exposed to someone with one of these diseases, talk with your doctor about getting MMR Vaccine. It is not harmful to get MMR Vaccine after being exposed to measles, mumps, or rubella, and doing so may possibly prevent later disease. If you get MMR Vaccine within 72 hours of initially being exposed to measles, you may get some protection against disease, or have milder illness. In other cases, you may be given medicine called immunoglobulin within six days of being exposed to measles, to provide some protection against disease, or have milder illness. Unlike with measles, MMR has not been shown to be effective at preventing mumps or rubella in people already infected with the virus. During outbreaks of measles or mumps, everyone without presumptive evidence of immunity should be brought up to date on their MMR vaccination. And some people WHO are already up to date on their MMR vaccination may be recommended to get an additional dose of MMR for added protection against disease.


Who Should Get MMR Vaccine?

Cdc recommends all children get two doses of MMR vaccine, starting with the first dose at 12 through 15 months of age, and the second dose at 4 through 6 years of age. Children can receive second dose earlier as long as it is at least 28 days after the first dose. The MMR vaccine is given later than some other childhood vaccines because antibodies transferred from mother to baby can provide some protection from disease and make the MMR vaccine less effective until about 1 year of age. Learn about the MMRV vaccine, which protects against measles, Mumps, Rubella, and varicella. This vaccine is only licensed for use in children who are 12 months through 12 years of age.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

MMR Immunization Schedule

For Vaccine Recommendations For Persons Age 0 through 18 years, see Child and Adolescent Immunization Schedule. Anatomical or functional asplenia: 1 dose If previously not received Hib; If elective splenectomy, 1 dose, preferably at least 14 days before splenectomy Hematopoietic stem cell transplant: 3 - dose series 4 weeks apart starting 6 - 12 months after successful transplant, regardless of Hib Vaccination History not at risk but want protection from hepatitis: 2 - dose series HepA or 3 - dose series HepA - HepB At risk For hepatitis virus infection: 2 - dose series HepA or 3 - dose series HepA - HepB as above Chronic liver Disease HIV infection Men who have sex With Men Injection or noninjection drug use Persons experiencing homelessness Work With hepatitis virus in research laboratory or With nonhuman primates With hepatitis virus infection Travel in countries With high or intermediate endemic hepatitis Close, personal contact With international adoptee in First 60 days after arrival from country With high or intermediate endemic hepatitis Pregnancy If At risk For infection or Severe outcome from infection during Pregnancy Settings For exposure, including Health care Settings targeting services to Injection or noninjection drug users or group homes and nonresidential day care facilities For developmentally disabled Persons not At risk but want protection from hepatitis B: 2 - or 3 - dose series or 3 - dose series HepA - HepB At risk For hepatitis B virus infection: 2 - dose or 3 - dose series or 3 - dose series HepA - HepB as above Chronic liver Disease HIV infection Sexual exposure risk current or recent Injection drug use Percutaneous or mucosal risk For exposure to blood incarcerated Persons Travel in countries With high or intermediate endemic hepatitis B Pregnancy If At risk For infection or Severe outcome from infection during Pregnancy. Heplisav - B is not currently recommended due to lack of safety data in pregnant women. Hpv Vaccination recommended for all adults through age 26 years: 2 - or 3 - dose series depending on age At initial Vaccination or condition: Age 15 years or older At initial Vaccination: 3 - dose series At 0 1 - 2 6 months Age 9 through 14 years At initial Vaccination and receive 1 dose or 2 doses less than 5 months apart: 1 dose Age 9 through 14 years At initial Vaccination and receive 2 doses At least 5 months apart: HPV Vaccination complete, no additional dose need. If complete valid Vaccination series with any HPV Vaccine, no additional doses needed age 27 through 45 years based on shared clinical decision - making: 2 - or 3 - dose series as above Pregnancy through age 26 years: HPV Vaccination not recommended until after Pregnancy; no intervention needed if vaccinated while pregnant; Pregnancy testing not need before Vaccination Persons Age 6 months or older: 1 dose any influenza Vaccine appropriate For Age and Health status annually For additional guidance, see www. Cdc. Gov / flu / professionals / index.


Who Should Get MMR Vaccine?

People 6 months of age and older who will be traveling internationally should be protected against measles. Before any international travel, infants 6 through 11 months of age should receive one dose of MMR vaccine. Infants who get one dose of MMR vaccine before their first birthday should get two more doses. Children 12 months of age and older should receive two doses of MMR vaccine, separate by at least 28 days. Teenagers and adults who do not have presumptive evidence of immunity against measles should get two doses of MMR vaccine separate for at least 28 days. See also, Travel Information

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Background

The INTRODUCTION of Measles vaccination in 1960s helped to control this highly contagious disease. Elimination was achieved in the Americas in 2002 and the World Health Organization has set a goal of Measles elimination. In one - dose programs, vaccine effectiveness was influenced by the age of vaccination. Interference of maternal antibodies and immaturity of children's immune system are alleged mechanisms that result in weaker antibody response and poorer protection in younger infants. A second dose of MCV was added to compensate for primary failures observed after first vaccination, and two - dose schedules have been key strategy for Measles elimination. However, epidemic investigations and serological studies have suggested that the effect of age on MCV1 could persist after two doses, with increased vulnerability among children first vaccinated before 15 months. The recommend age at first dose is compromise, balancing the advantage of older immunization with the risk of Measles in infants. Depending upon country, first dose of Measles - containing Vaccine is currently administered from 9 to 18 months of age, with vaccination recommended as early as 6 months in specific situations. In their systematic review, Uzicanin and Zimmerman reported VE of 84 to 93% after one and of 94% after two doses of Vaccine. They present VE summary point estimates for one dose administered at 9 - 11 or 12 months. The Cochrane review studies the effectiveness and safety of Measles - mumps - rubella Vaccine but without accounting for age at vaccination. Finally, recent review examined immunogenicity and effectiveness of vaccination at < 9 months. None of them have systematically reviewed the impact of change in age at MCV1 on Vaccine response. In order to control Measles or to maintain Measles elimination, Public Health stakeholders have to decide on the best vaccination schedules based on their country's epidemiology, Health System characteristics and best evidence on the effect of age at vaccination. We aim to evaluate the effect of age at administration of MCV1 on protection against Measles and antibody response after one - and two - dose Measles vaccinations through systematic review of observational studies estimating VE and / or Measles attack rates by age at first vaccination as well as experimental studies comparing seroconversion risk by age at first vaccination.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Results

The Median anti - Measles Antibody titer was 1350. 35 mIU / ML. Titer differ among age groups. Older individuals WHO acquire infection tend naturally to have higher titers than younger individuals WHO are likely to have acquired their immunity from vaccination. A total of 1830 individuals were positive for Measles antibodies, giving a seroprevalence of 93. 4%; 76 individuals were equivocal; and 54 were negative for Measles antibodies. Seropositivity differed among age groups: 5 age groups had seropositivity rates of > 90%, and 3 groups had seropositivity rates of < 90%. In children < 1 y, 85. 2% were found to be seropositive. Seroprevalence rates significantly increase in children aged 1 - 4 y. Then, there was a decrease in seroprevalence until age 20 - 29 y. Seroprevalence rates significantly increased to 94. 7% and 97. 6% in the 30 - 39 and 40 - age groups, respectively. The proportion of equivocal sera was unevenly distributed by age group, increasing steadily from 1 y to 20 - 29 y. In the 20 - 29 y age group, proportion of equivocal sera was significantly higher than that observed in all other age groups. By contrast, < 3% of adults aged 30 y had equivocal results.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Discussion

The Advisory Committee on Immunization Practices recommends a two - dose vaccine schedule for measles, mumps, rubella and varicella vaccines for children, with the first dose at age 12 - 15 months and the second at age 4 - 6 years. Two Vaccination options considered equivalent in terms of disease protection can be used to implement ACIP recommendation among children 12 months - 12 years of age: administration of trivalent measles, mumps, and rubella Vaccine and varicella Vaccine, or quadrivalent measles, mumps, rubella and varicella Vaccine. This web page was designed to answer questions that healthcare providers may have about vaccination options and febrile seizures. There are two options for protecting children WHO are 12 months - 12 years old against measles, mumps, rubella, and varicella: using varicella Vaccine and trivalent measles, mumps, and rubella Vaccine or using quadrivalent measles, mumps, rubella, and varicella Vaccine. This means that parents and caregivers have a decision to make, and they will rely on you as their children's healthcare provider for help in making that decision. Using MMRV Vaccine does result in one fewer injection, which may appeal to many parents. However, when used as first dose at ages 12 - 23 months, studies have shown that this benefit comes with a tradeoff: at this age, MMRV Vaccine is associated with higher risks of fever within 42 days after Vaccination and febrile seizures during 5 - 12 days after Vaccination when compared with administration of first dose MMR and varicella vaccines at same visit. Data are limited to this age group, but experts agree that this increases the risk of fever and febrile seizures during 5 - 12 days after first dose of MMRV Vaccination likely also occurs in children aged 24 - 47 months. As you know, questions or concerns about vaccines can be a source of stress for some parents during well - child visit. As their children's healthcare provider, you remain the parents ' most trusted source of information about vaccines. For first dose of measles, mumps, rubella, and varicella vaccines given at ages 12 - 47 months, either MMR and varicella vaccines or MMRV Vaccine can be used. However, if you are considering using MMRV Vaccine for children in this age group, it is important to take time to talk with parents or caregivers about the benefits and risks of both vaccination options. Unless a parent or caregiver expresses preference for MMRV Vaccine, CDC recommends that MMR Vaccine and varicella Vaccine should be administered as separate injections for first dose in children 12 - 47 months of age. Discussing whether to use MMRV Vaccine or MMR and varicella vaccines for 12 - 47 - month - olds first Vaccination centers on helping parents understand the risk / benefit tradeoff. About 2 - 5 percent of young children will have at least one febrile seizure. Febrile seizures usually occur in children aged 6 - 60 months. The peak age for febrile seizures is 14 - 18 months, which overlaps with ages when first doses of measles, mumps, rubella and varicella vaccines are recommend.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Who Should Get MMR Vaccine?

MMR Vaccine is very effective at protecting people against measles, Mumps, and Rubella, and preventing complications caused by these diseases. People WHO receive two doses of MMR Vaccine as children according to the US vaccination schedule are usually considered protected for life and do need a booster dose. Additional doses may be needed if you are at risk because of a Mumps outbreak. One dose of MMR Vaccine is 93% effective against measles, 78% effective against Mumps, and 97% effective against Rubella. Two doses of MMR Vaccine are 97% effective against measles and 88% effective against Mumps. Mmr is an attenuated LIVE virus vaccine. This means that after injection, viruses cause harmless infection in vaccinated person with very few, if any, symptoms before they are eliminated from the body. A person's immune system fights infection caused by these weakened viruses, and immunity develops. Some people WHO get two doses of MMR Vaccine may still get measles, Mumps, or Rubella if they are exposed to viruses that cause these diseases. Experts are not sure why; it could be that their immune systems didnt respond as well as they should have to vaccine or their immune systems ' ability to fight infection decreased over time. However, disease symptoms are generally milder in vaccinated people. About 3 out of 100 people WHO get two doses of MMR Vaccine will get measles if exposed to the virus. However, they are more likely to have milder illnesses and are also less likely to spread disease to other people. Two doses of MMR Vaccine are 88% effective at preventing Mumps. Mumps outbreaks can still occur in highly vaccinated US communities, particularly in settings where people have close, prolonged contact, such as universities and close - knit communities. During an outbreak, public health authorities may recommend additional doses of MMR for people WHO belong to groups at increased risk for Mumps. Additional doses can help improve protection against Mumps Disease and related complications. While there are not many studies available, most people WHO do not respond to the Rubella component of the first MMR dose would be expected to respond to the second dose.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

What is MMRV Vaccine?

MMRV Vaccine protects against four diseases: measles, mumps, rubella, and varicella. This vaccine is only licensed for use in children 12 months through 12 years of age. Cdc recommends that children get one dose of MMRV Vaccine at 12 through 15 months of age, and a second dose at 4 through 6 years of age. Children can receive a second dose of MMRV Vaccine earlier than 4 to 6 years. This second dose of MMRV Vaccine can be given 3 months after the first dose. A doctor can help parents decide whether to use this vaccine or MMR Vaccine. Mmrv is given by shot and may be given at the same time as other vaccines. Please see the MMRV Vaccine Information Statement for more information about who should not get MMRV Vaccine or should wait.


Who Should Get MMR Vaccine?

Some people should not get the MMR vaccine or should wait. Tell your vaccine provider if the person getting the vaccine: has any severe, life - threatening allergies. Person who has ever had life - threatening allergic reaction after dose of MMR vaccine, or has severe allergy to any part of this vaccine, may be advised not to be vaccinate. Ask your health care provider if you want information about vaccine components. Is pregnant, or think she might be pregnant. Pregnant women should wait to get MMR vaccine until after they are no longer pregnant. Women should avoid getting pregnant for at least 1 month after getting the MMR vaccine. Has weakened immune system due to disease or medical treatments. Has parent, brother, or sister with a history of immune system problems. Has ever had conditions that make them bruise or bleed easily. Has recently had blood transfusion or received other blood products. You might be advised to postpone MMR vaccination for 3 months or more. Has tuberculosis. He has get any other vaccines in the past 4 weeks. Live vaccines given too close together might not work as well. Is not feeling well. Mild illness, such as cold, is usually not a reason to postpone vaccination. Someone who is moderately or severely ill should probably wait. Your doctor can advise you. This information was taken directly from MMR vaccine information Statement date 2 / 12 / 2018. Learn who should not get the MMRV vaccine, which protects against measles, Mumps, Rubella, and varicella. This vaccine is only licensed for use in children who are 12 months through 12 years of age.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Educational Materials

Cdc recommends that people get the MMR vaccine to protect against Measles, Mumps, and Rubella. Children should get two doses of MMR vaccine, starting with the first dose at 12 to 15 months of age, and the second dose at 4 through 6 years of age. Teens and adults should also be up to date on their MMR vaccination. Children may also get the MMRV vaccine, which protects against Measles, Mumps, Rubella, and Varicella. This vaccine is only licensed for use in children who are 12 months through 12 years of age. Cdc Fact Sheets for Parents Measles Mumps Rubella information on vaccines. Gov CDC Feature Stories Measles: Make Sure Your Child Is Fully Immunized Mumps: Be Sure Your Child Is Fully Immunized Rubella: Make Sure Your Child gets vaccinated What Would Happen If We stop Vaccinations? Questions and Answers, Immunization Action Coalition Measles, Mumps, and Rubella are serious diseasesMake. Sure Your Child is safe Immunization Action Coalition

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

MMR at 1 year

Measles is an acute, highly contagious illness caused by a virus in the family paramyxovirus, genus Morbillivirus. 2 Measles presents with symptoms of fever, malaise, cough, coryza, and conjunctivitis, followed by characteristic maculopapular rash and Koplik spots. 2 Disease was nearly universal during childhood in the United States prior to vaccination. 3 Approximately 500 000 cases and 500 deaths were reported annually in the United States before the vaccine was available. 3 in 1963, live vaccine was licensed for use as single dose at age 9 months. With the exception of oral poliovirus strains, complication rates during the first year of life have been higher for other diseases when live vaccines were used compared to complication rates when live vaccines were given after the first birthday. 4 For this reason, in 1965, schedule was moved to administer vaccine at 12 months of age. 5 challenges seen in the first few years after the live vaccine was developed were attributed to multiple factors. Simultaneous inoculation with - globulin, diminished potency caused by mishandled storage conditions, and persistence of passively acquired maternal antibody, among others, were reported as causes of vaccine failure. 6 in 1977, Yeager et al 7 show that children immunized at 13 to 14 months of age show higher antibody titers compared to children WHO had received their Measles vaccine at 12 months or earlier. Albrecht et al 8 evaluates maternal transmission of Measles antibodies. They conducted a prospective study of thirty - four 12 - month - old children and found that maternal Measles - neutralizing antibodies may persist up to and beyond 12 months of age. A direct correlation of persisting levels of maternal antibody in infants and decreased response to immunization was observe. 8 With a growing body of evidence, ACIP recommends that the schedule dose of Measles vaccine be changed to 15 months. 6 in the mid - 1980s, there still were concerns regarding maternal transmission of immunity against Measles in infants, especially in young mothers WHO had received vaccine. Studies show that women born after 1956 were more likely to have vaccine - induced immunity, transferring lower titers of Measles antibodies to their infants. 9 10 Additionally, maternal antibodies wan earlier, causing preterm infants to become susceptible to Measles at a younger age. 10 Jenks et al 11 evaluates Measles antibody levels in children born to unvaccinated mothers at different gestational ages. Because most maternal antibodies are transferred to the fetus during the third trimester, these preterm infants are at particular risk of having low or even undetectable antibody titers by their first year of life and may benefit from earlier administration of vaccine. Public Health authorities acknowledge these cases were exceptions rather than rule, therefore change in schedule was not warrant. They suggest that each patient should be evaluated independently, and early administration close to 12 months should be considered in those with highest risk. The Centers For Disease Control reported 6282 cases of Measles in 152 outbreaks from 1985 through 1986.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Sources

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

logo

Plex.page is an Online Knowledge, where all the summaries are written by a machine. We aim to collect all the knowledge the World Wide Web has to offer.

Partners:
Nvidia inception logo

© All rights reserved
2021 made by Algoritmi Vision Inc.

If you believe that any of the summaries on our website lead to misinformation, don't hesitate to contact us. We will immediately review it and remove the summaries if necessary.

If your domain is listed as one of the sources on any summary, you can consider participating in the "Online Knowledge" program, if you want to proceed, please follow these instructions to apply.
However, if you still want us to remove all links leading to your domain from Plex.page and never use your website as a source, please follow these instructions.